Log In
BCIQ
Print this Print this
 

Zilretta (FX006)

  Manage Alerts
Collapse Summary General Information
Company Flexion Therapeutics Inc.
DescriptionSustained-release intra-articular formulation of triamcinolone acetonide (TCA)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsTreat moderate to severe osteoarthritis (OA) pain; Treat pain associated with osteoarthritis (OA) of the knee
Regulatory Designation U.S. - Fast Track (Treat pain associated with osteoarthritis (OA) of the knee)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today